Evaluating Cloudbreak Molecule for Protection Against Acinetobacter Pneumonia
April 16th 2019A study found that the molecule, Compound A, has potent activity against Acinetobacter Pneumonia in mice possibly by a dual killing mechanism and by reducing lipopolysaccharide-induced vascular leak.
Read More